Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inozyme Pharma

0.9829
+0.02292.39%
Volume:170.35K
Turnover:163.76K
Market Cap:63.14M
PE:-0.61
High:0.9987
Open:0.9600
Low:0.9402
Close:0.9600
Loading ...
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2022

Major Issues Report

8-K - Current report
Jul 19, 2022

Major Issues Report

8-K - Current report
Jun 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 28, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Apr 28, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 19, 2022

Major Issues Report

8-K - Current report
Apr 18, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals